Medical devices, healthcare technology and the business of care
PMA SUPPLEMENT · P980018/S027

HercepTest

Agilent Technologies Singapore (International) Pte , Ltd. · Decision date Sep 21, 2026

MEDTECHLEDGER EXPLANATIONP980018/S027

What did the FDA decide?

This record documents a 30-Day Notice supplement to PMA P980018, submitted by Agilent Technologies Singapore (International) Pte, Ltd. The reported statement describes approval for a supplier's change to the manufacturing site for a device component. The associated reason code is Process Change - Manufacturer/Sterilizer/Packager/Supplier. The device category is listed as SYSTEM, TEST, HER-2/NEU, IHC, under product code MVC, specialty Pathology.

The supplemental identifier P980018/S027 ties the notice to original PMA P980018, so a manufacturing-site change is not an approval of the whole HercepTest system. The record does not name the component, the prior or new manufacturing site, or any validation data, and it does not establish safety or clinical effectiveness. The stated purpose is a supplier manufacturing-site change; the source gives no further technical detail.

Researchers should read this as a descriptive database entry limited to that scope, without inferring new indications, performance changes, or trial data.

FDA approval order statement

approval for a supplier's change to the manufacturing sight for a device component
Regulatory pathway
PMA supplement
Supplement type
30-Day Notice
Clinical specialty
Pathology
Decision date
Sep 21, 2026
FDA change category
Process Change - Manufacturer/Sterilizer/Packager/Supplier

FDA source record · MedtechLedger’s explanation describes the recorded change.

Regulatory record facts

Identifier
P980018/S027
Regulatory pathway
PMA supplement
Product code
MVC
Decision code
OK30
Decision date
Sep 21, 2026
Source update
Nov 9, 2026
Original record
Open FDA source record

About this medical device

FDA device category: SYSTEM, TEST, HER-2/NEU, IHC.

Product code
MVC
FDA device class
3

For the original device and its historical approval scope, see PMA P980018. Subsequent supplements may change the device or its indications.

FDA decision timeline

  1. P980018/S027 received

    Application receipt date recorded by FDA.

  2. P980018/S027 · FDA decision

    30-Day Notice

Timeline entries are records held by MedtechLedger for P980018. View FDA’s full supplement list.

Related devices and submissions

Same PMA: P980018

Product / regulatory recordCompanyPathwayDecision dateSource
Agilent Technologies Singapore (International) Pte , Ltd.PMA approvalSep 25, 1998FDA

Explore the linked device profile

Regulatory context

A PMA supplement records a change to a device with an existing premarket approval. The supplement’s approval applies to the change described in that submission.

Read our guide to FDA clearance and approval · FDA’s explanation of this pathway

Manufacturer intelligence

Agilent Technologies Singapore (International) Pte , Ltd.

Headquarters
Not reported
Brand website
Not reported
FDA applicant address
# 1 Yishun Ave. 7, Singapore, 768923

Sources and methodology

FDA fields and approval-order wording are presented as source information. MedtechLedger explanations are identified separately and describe the scope of the recorded decision. Indications from an original PMA are historical unless confirmed against subsequent labeling and supplements.

How we use FDA records